baber/WOPTO huggingface dataset:
Patent JP-4064235-B2 (JP)
IPC: F16F9/516
Filed: 2001-04-26
Granted: 2008-03-19
Abstract: A cam member 5 is disposed within a first chamber R1 such that the cam member 5 is rotatable but non-movable in the axial direction. The cam member 5 is non-rotatably connected to a rotor 3 through a connection shaft portion 52 piercing into a piston 4. A second cam mechanism 10 is disposed between the cam member 5 and the piston 4. When the cam mechanism 7 causes the piston 4 to move from the second chamber R2 side to the first chamber R1 side in accordance with rotation of the rotor 3 in one direction, the second cam mechanism 10 allows the piston 4 to move from the second chamber R2 side to the first chamber R1 side by the same amount of movement. When the second cam mechanism 10 causes the piston 4 to move from the first chamber R1 side to the second chamber R2 side in accordance with rotation of the rotor 3 in the other direction, the cam mechanism 7 allows the piston 4 to move from the first chamber R1 side to the second chamber R2 side by the same amount of movement.
Patent JP-3984547-B2 (JP)
IPC: B60S1/38
Filed: 2001-11-28
Granted: 2007-10-03
Abstract: The invention is based on a wiper arm (10), with a pivotably connected wiper blade (16), which includes at least one bracket (18,20,22) and a wiper strip (26) and which is guided laterally in relation to the wiper arm (10) by a device (32,44,58). A first part (34,48,62) of the device (32,44,58) associated with the wiper arm (10) is connected to a second part (36,46) associated with the wiper blade (16) by means of a link (38,50,60), which flexes approximately perpendicular to the windshield (30). The invention proposes that the second part (36,46) be permanently connected to the wiper blade (16).
Patent JP-4234439-B2 (JP)
IPC: C08B37/08
Filed: 2002-03-14
Granted: 2009-03-04
Abstract: An object of the present invention is to provide an IL-12 expression controlling agent, an inhibitor of IL-12 expression and an enhancer of IL-12 expression for oral administration, which comprise hyaluronan as an active ingredient. The present invention relates to an interleukin-12 expression controlling agent, which comprises hyaluronan as an active ingredient. Specifically, it is an inhibitor of interleukin-12 expression, which comprises hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 600,000 to 3,000,000 as an active ingredient, or an enhancer of interleukin-12 expression for oral administration, which comprise hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 50,000 to 400,000 as an active ingredient.
Patent JP-4653934-B2 (JP)
IPC: A61K39/00
Filed: 2002-03-25
Granted: 2011-03-16
Abstract: The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.
Patent JP-4205436-B2 (JP)
IPC: C08L7/00
Filed: 2002-05-07
Granted: 2009-01-07
Abstract: A composition having a reduced hysteresis which is usable in a crown reinforcement for a heavy-vehicle tire, includes an elastomeric matrix comprising natural rubber or a synthetic polyisoprene in a majority proportion, and a reinforcing filler comprising a carbon black, where the carbon black fulfills the following conditions: (i) 45≰CTAB specific surface area in m2/g≰70, (ii) 45≰BET specific surface area in m2/g≰70, (iii) 45≰iodine adsorption index IA in mg/g≰70, (iv) ratio (BET surface area/index IA)≰1.07, (v) 115≰DBP structure value in ml/100 g≰170, (vi) 85 nm≰Stokes diameter dst in nm≰145, where dst is the diameter of aggregates corresponding to the maximum frequency of the Stokes diameters in a distribution of aggregates, and (vii) D50/dst≰0.0090·CTAB+0.19, where D50 is the difference, in the distribution of aggregates, between the Stokes diameters of two aggregates corresponding to one and the same frequency equal to 50% of the maximum frequency of the Stokes diameters, dst and D50 being measured by centrifugal photosedimentometry.
Patent JP-4137646-B2 (JP)
IPC: F04B39/00
Filed: 2002-03-14
Granted: 2008-08-20
Abstract: In a reciprocating-piston machine, in particular a refrigerant compressor for a motor vehicle air-conditioning system, including a machine shaft, a plurality of pistons are arranged, at the same distance from the machine shaft, on a cylinder envelope defined by the axes of the pistons and extending around the machine shaft, and an annular pivoting disc which is driven by the machine shaft and which engages the pistons via a joint arrangement, the joint arrangement has an at least partially spherical receptacle, in which at least one sliding element structure is arranged moveably relative to the associated piston and relative to the pivoting disc, including a first sliding element having a first sliding face in the form of a spherical segment with a first geometric center (M<SUB>1</SUB>, M<SUB>3</SUB>), and a second sliding element having a second sliding face in the form of a spherical segment with a second geometric center (M<SUB>2</SUB>, M<SUB>4</SUB>) arranged at a distance from the first geometric center.
Patent JP-4348101-B2 (JP)
IPC: A61M1/34
Filed: 2003-03-24
Granted: 2009-10-21
Abstract: The monitoring method uses measurement of the propagation time of the pressure wave of the substitution fluid feed pump (22) between the latter and the extracorporal blood circuit (5A) for determining the substitution fluid feed ahead or after the blood filter (1).  An Independent claim for an extracorporal blood treatment device is also included.
Patent JP-4077400-B2 (JP)
IPC: G01C21/34
Filed: 2003-12-22
Granted: 2008-04-16
Abstract: A guidance information providing apparatus comprises a first memory to store network data including line segment data representing a passage in a target area of route guidance in an information map and point data representing a connecting point of a passage, a second memory store three-dimensional shape data representing a three-dimensional shape of the target area, a route search unit which searches for a guiding route connecting an input departure place and destination, a setting unit which sets viewpoint position candidates, an evaluation unit which obtains an evaluation value, from each viewpoint position candidate, an generating unit which determines a viewpoint position, on the basis of the evaluation value of visibility from each viewpoint position candidate, and generates the information map by projecting the three-dimensional shape data, and a presentation unit which presents the generated information map to a user.
Patent JP-4048168-B2 (JP)
IPC: C08L53/00
Filed: 2001-12-26
Granted: 2008-02-13
Abstract: The present invention relates to a flame retardant thermoplastic resin composition that contains a phenol resin derivative having good char formability, regardless of the base resin. A flame retardant thermoplastic resin composition according to the present invention comprises (A) 100 parts by weight of a thermoplastic resin as a base resin, (B) about 0.1~100 parts by weight of a phenol resin derivative, and (C) about 0.1~50 parts by weight of a phosphorous compound or a mixture of phosphorous compounds.
Patent JP-3952201-B2 (JP)
IPC: A61K35/74
Filed: 2001-12-12
Granted: 2007-08-01
Abstract: The present invention is directed to the oncolytic microorganisms expressing Heat Shock Protein, compositions or pharmaceutical compositions containing them, and to methods of kilking local and metastatic tumors using them. The microorganisms refer to viruses and bacteria, which can grow selectively within tumor cells in order to lyse tumor cells. Upon the microorganisms or compositions according to the present invention is administrated to a tumor patient, the oncolytic microorganisms lye tumor cells and the heat shock proteins expressed by the oncolytic microorganisms or administered simultaneously with the oncolytic microorganisms adhere to tumor antigen released by the lysing tumor cells, and bind to antigen-presenting cells so as to induce specific immune response against tumor cells, then to kill metastatic tumors.
Patent JP-4473579-B2 (JP)
IPC: F16F1/14
Filed: 2002-12-04
Granted: 2010-06-02
Abstract: The rotational spring includes a base member which is in the form of a ring and includes elements for fixedly attaching it to a body of an appliance, such as a power toothbrush, which includes a drive element such as a drive shaft portion of a motor. Also included is an upper member in the form of a disc having a central opening through which the drive shaft is fitted, such that the disc member rotates with rotation of the drive shaft. Three leg members extend between the upper disc member and the base ring member. The spring is made from a material and is so configured and arranged that it has a symmetric spring rate for clockwise and counter-clockwise rotation.
Patent JP-4198601-B2 (JP)
IPC: B28D5/00
Filed: 2003-04-01
Granted: 2008-12-17
Abstract: The substrate made of the fragile material is scribed, after a protective element is applied onto a surface of the substrate. The cullet produced while cutting the substrate along the scribe line by forming a vertical crack extending deep into the substrate, is removed. An independent claim is also included for fragile substrate cutting device.
Patent JP-4810653-B2 (JP)
IPC: H04L1/00
Filed: 2004-10-26
Granted: 2011-11-09
Abstract: A communication system including a first device transmitting a modulated signal and a second device receiving the modulated signal. The second device can include a first demodulator and a second demodulator. The first demodulator can receive the modulated signal, produce a first demodulated output, and implement a first demodulation technique. The second demodulator can receive the modulated signal, produce a second demodulated output, and implement a second demodulation technique. The second demodulation technique can differ from the first demodulation technique. The second device can also include an error detection module that can perform bit error detection based on the first demodulated output and the second demodulated output.
Patent JP-4373330-B2 (JP)
IPC: H04L25/00
Filed: 2003-07-18
Granted: 2009-11-25
Abstract: A method and apparatus for a decision feedback equalizer wherein a correction term is used to compensate for slicer errors, thus avoiding error propagation. Filter coefficients for the equalizer are selected so as to minimize a cost function for the equalizer, including a correction term as a function of the energy of the filter coefficients. The equalizer includes a coefficient generator responsive to the correction term. One embodiment estimates a transmitted symbol from a received sample as a function of Signal-to-Interference and Noise Ratio (SINR) of the received sample. The received sample is quantized and mapped to a region of a grid overlaid on the transmitted symbol constellation. The region may correspond to a symbol estimate value or may be processed further to obtain a symbol estimate value.
Patent JP-3678366-B2 (JP)
IPC: A61P17/02
Filed: 2003-08-07
Granted: 2005-08-03
Abstract: A method of treating atopy-evoked pruritic symptoms by administering a prostaglandin derivative.
Patent JP-4394574-B2 (JP)
IPC: H04M3/12
Filed: 2003-08-12
Granted: 2010-01-06
Abstract: A method includes receiving information at an interface circuit and providing the information from the interface circuit to a processing circuit through a direct communications path between the interface circuit and a processing circuit, which processes the information received from the interface circuit. The method further includes providing the information from the interface circuit to the processing circuit via a crosspoint switch in response to a failure of the direct communications path, wherein the direct communication does not pass through the crosspoint switch.
Patent JP-4528624-B2 (JP)
IPC: C12P7/60
Filed: 2003-09-22
Granted: 2010-08-18
Abstract: The present invention relates to a novel DNA which encodes aldehyde dehydrogenase (SNDH), an expression vector containing the DNA and recombinant organisms containing said DNA. Furthermore, the present invention concerns a process for producing recombinant aldehyde dehydrogenase protein and a process for producing L-ascorbic acid (vitamin C) and/or 2-keto-L-gulonic acid (2-KGA) from L-sorbosone by using the recombinant aldehyde dehydrogenase protein or recombinant organisms containing the expression vector. Also provided is a process for the production of 2KGA with a microorganism in which the gene encoding said aldehyde dehydrogenase is disrupted.
Patent JP-4902977-B2 (JP)
IPC: H02K5/24
Filed: 2005-08-17
Granted: 2012-03-21
Abstract: The vibration absorption structures (50,70) are provided overmolded to the fixing housing that accommodates the sleeve which receives the motor. The vibration absorption structure (50) comprises insulating pads (40) that mate with the guide fingers. The vibration absorption structure (70) comprises longitudinal strands (60) that mate with the sleeve.
Patent JP-4413856-B2 (JP)
IPC: B60J3/00
Filed: 2005-11-30
Granted: 2010-02-10
Abstract: Roller blind arrangement (14) has a roller spindle (19) linked up in the direction of clockwork motor (21). Edges of the guide rails (16) are fastened to the roller spindle with roller blind web (15). A tension member (22) is connected to the movable edge of the guide rails. Locking members (36,47,48,51) are being operated on or at the tension members effectively. The tension member leads around the axle is defined by the rotating edges (51) of the two locking mechanism in such a way to avoid the interference with the rest counter bearing.
Patent JP-4555772-B2 (JP)
IPC: A61K8/27
Filed: 2005-12-26
Granted: 2010-10-06
Abstract: Pyrogenically prepared, surface-modified silicon dioxide-titanium dioxide-mixed oxides (I) are new. Independent claims are also included for: (1) the preparations of (I); and (2) a sun protective agent (II) comprising 0.1-25 wt.% of (I).
Patent JP-5296968-B2 (JP)
IPC: A61K31/522
Filed: 2006-06-14
Granted: 2013-09-25
Abstract: <P>PROBLEM TO BE SOLVED: To obtain an ibuprofen-containing oral medicinal composition having reduced gastric mucosa disorder by ibuprofen.  <P>SOLUTION: The oral medicinal composition reduces gastric mucosa disorder by ibuprofen and comprises 1 part wt. of ibuprofen and 0.75-8 parts wt. of magnesium oxide.  <P>COPYRIGHT: (C)2007,JPO&INPIT
Patent JP-4472672-B2 (JP)
IPC: A61K35/16
Filed: 2006-08-02
Granted: 2010-06-02
Abstract: The invention relates to a composition intended to stabilise blood plasma during pasteurisation, the blood plasma being whole or devoid of cryoproteins. The composition according to the invention makes it possible to pasteurise very large quantities of plasma (of the order of 60 litres). The invention also relates to the method for pasteurisation of the plasma using the stabilising composition. The pasteurised plasma obtained is intended for therapeutic use.
Patent JP-4211831-B2 (JP)
IPC: B60L50/16
Filed: 2006-09-14
Granted: 2009-01-21
Abstract: When curve determine signal from a navigation apparatus is activated, a learning portion learns driver's characteristics based on an accelerator pedal opening degree signal, and outputs the result of learning in association with a user ID from the navigation apparatus to a storage portion. A threshold value changing portion reads a learned value corresponding to the user ID from the storage portion, and based on the learned value, changes a threshold value for switching that is used by a traveling control portion. The traveling control portion switches between traveling modes based on a result of comparison between traveling power and the threshold value for switching.
Patent JP-4505452-B2 (JP)
IPC: A61K31/66
Filed: 2004-03-19
Granted: 2010-07-21
Abstract: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
Patent JP-4663625-B2 (JP)
IPC: G10H1/00
Filed: 2004-03-25
Granted: 2011-04-06
Abstract: The present invention consists in a method and electronic device used to reproduce the sound of church organ flue pipes, by taking advantage of the physical modeling technique of acoustic instruments; it being an audio-digital synthesis system based on digital signal processors, which contains a program of physical simulation of the generation of the sound of organ flue pipes.
Patent JP-4859124-B2 (JP)
IPC: H01M8/00
Filed: 2004-03-30
Granted: 2012-01-25
Abstract: The invention relates to a membrane electrode unit for electrochemical apparatuses, in particular for direct methanol fuel cells (DMFC) and a method for the production thereof. The multilayer MEUs for DMFC according to the invention comprise of an anode gas diffusion substrate, an anode catalyst layer, an ionomer membrane, a cathode catalyst layer and a cathode gas diffusion substrate, the anode catalyst layer being applied to the anode gas diffusion substrate, while the cathode catalyst layer is present directly on the membrane. Improved power values in combination with reduced precious metal consumption can be achieved thereby.
Patent JP-4500811-B2 (JP)
IPC: C08F2/24
Filed: 2004-06-16
Granted: 2010-07-14
Abstract: Disclosed herein is a process for preparing a shelf-stable, one-pack, silane modified (meth)acrylic latex interpolymer composition, wherein the process comprises continuously adding at least a portion of a mixture comprising at least 0.5 mole percent of a vinyl silane comprising hydrolyzable groups and up to 99.5 mole percent of a (meth)acrylic monomer to water and a surfactant in a reaction vessel, wherein said addition is carried out in the presence of a polymerization initiator and buffer sufficient to maintain the pH of the reaction at a level of at least 6 throughout the reaction, while simultaneously hydrolyzing from about 10 to about 60% of the hydrolyzable groups of the vinyl silane.
Patent JP-4410250-B2 (JP)
IPC: B24B13/005
Filed: 2004-07-12
Granted: 2010-02-03
Abstract: Tool (1) for planing an optical surface (2) has a rigid support (4) with an end transverse surface (13), an elastically compressible interface (5) that is applied against and covers the end surface and a flexible tampon (6) able to be applied against the optical surface and that is applied against and covers at least partially the interface that it opposes and to the right of the end surface. The tampon includes a central part (6a) found to the right of the end surface and a peripheral part (14) found transversely on the other side of the end surface where are provided an elastic spring (15) comprising, in order to link this peripheral part to the support, a flange (18) presenting a peripheral part (22) continuously co-operating in thrust with the peripheral part of the tampon.
Patent JP-4662938-B2 (JP)
IPC: F02D41/12
Filed: 2004-09-28
Granted: 2011-03-30
Abstract: The invention relates to a method for controlling the opening and closing of the intake valves of an internal combustion engine with a direct fuel injection system, comprising at least one first intake valve and a second intake valve per cylinder, wherein each valve respectively opening or closing a first and second intake duct per cylinder can be controlled independently of the other valve, wherein at least one of the ducts is supplied with fuel and at least one of the other ducts is not supplied with fuel. According to the invention, said method consists in controlling the valve or valves corresponding to the intake ducts supplied with fuel during the time intervals when the injection system does not function. The invention also relates to a system for the application of said method.
Patent JP-4894517-B2 (JP)
IPC: C07D405/12
Filed: 2005-08-26
Granted: 2012-03-14
Abstract: The present invention relates to a novel 2-phenylpyridine derivative or a salt thereof, wherein the pyridine ring is substituted with a carboxyl group or the like and the benzene ring has an electron-withdrawing group such as a cyano group and an electron-donating group such as a substituted alkoxy group at the same time.  Since the compound of the invention has good xanthine oxidase-inhibitory action and uric acid-lowering action and does not have a structure derived from nucleic acid, the compound has advantages of high safety and excellent effects as compared with conventional compounds and is useful as a therapeutic or preventive agent for hyperuricemia, gout, inflammatory bowel diseases, diabetic kidney diseases, diabetic retinopathy, or the like.
Patent JP-4952249-B2 (JP)
IPC: G06F21/34
Filed: 2005-11-01
Granted: 2012-06-13
Abstract: A management system manages use of management object provided in facilities by using an information storage medium of a user. An entrance management apparatus, provided in the vicinity of an entrance of the facilities, stores use permission information for permitting the use of the management object on an information storage medium when the user enters the facilities. In the facilities, a use management apparatus, provided for each management object, controls availability or unavailability of the management object based on the use permission information stored on the information storage medium. Additionally, the use management apparatus stores, in the information storage medium, use information showing that the management object is used. Further, a room leaving management apparatus, provided in the vicinity of an exit of the facilities, manages leaving of the user based on the use information stored on the information storage medium. When the user leaves the facilities, it is controlled whether or not the user can leave the facilities, and use history information is stored, based on the use information.
Patent JP-4402695-B2 (JP)
IPC: D04H1/728
Filed: 2004-01-30
Granted: 2010-01-20
Abstract: A conventional electrospinning devices is problematic in that the productivity is low and a droplet, by which a spinning liquid is not formed into fiber but dropped in a drop shape, occurs, to thereby deteriorate the quality of a nonwoven fabric. To solve the above problem, the present invention provides an bottom-up electrospinning devices, comprising: a spinning liquid main tank 1; a metering pump 2; a nozzle block 4; nozzles 5 installed on the nozzle block; a collector 7 for collecting fibers being spun from the nozzle block; and a voltage generator 9 for applying a voltage to the nozzle block 4 and the collector 7, wherein [A] the outlets of nozzles 5 installed on a nozzle block are formed in an upper direction; [B] a collector 7 is located on the top part of the nozzle block; and [C] a spinning liquid discharge device 12 is connected to the uppermost part of the nozzle block 4.
Patent JP-4589339-B2 (JP)
IPC: A47J31/06
Filed: 2004-12-17
Granted: 2010-12-01
Abstract: A press assembly is adapted to be used with a disposable stackable cup. According to the preferred embodiment, the press includes a filter. A resilient radially compressible support forms a seal is formed between the filter and the interior of the cup. A detachable rod is mounted to the support. The support is sized to accommodate all radii of the cup. As the user presses down the rod, the press assembly is pushed downward to the bottom of the vessel. The seal maintains continual and firm pressure on the inside surface of the vessel so that the pressurized liquid passes through the filter and the infusion substance is trapped.